Michihiro Takahashi
Ashiya, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Remission, response, and relapse rates in patients with acute schizophrenia treated with olanzapine monotherapy or other atypical antipsychotic monotherapy: 12-month prospective observational study.
Journal: Pragmatic and observational research
Published: July 14, 2015
Efficacy and safety of atomoxetine hydrochloride in Korean adults with attention-deficit hyperactivity disorder.
Journal: Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists
Published: March 21, 2014
Erratum: A randomized, double-blind, placebo-controlled study of rapid-acting intramuscular olanzapine in Japanese patients for schizophrenia with acute agitation.
Journal: BMC psychiatry
Published: January 01, 2014
C3 dysregulation due to factor H deficiency is mannan-binding lectin-associated serine proteases (MASP)-1 and MASP-3 independent in vivo.
Journal: Clinical and experimental immunology
Published: November 20, 2013
Efficacy and Safety of Atomoxetine Hydrochloride in Asian Adults With ADHD.
Journal: Journal of attention disorders
Published: November 09, 2013
Safety and efficacy of olanzapine in the long-term treatment of Japanese patients with bipolar I disorder, depression: an integrated analysis.
Journal: Psychiatry and clinical neurosciences
Published: May 13, 2013
Long-term safety and tolerability of atomoxetine in Japanese adults with attention deficit hyperactivity disorder.
Journal: Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists
Published: March 14, 2013
Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Japanese subpopulation analysis of a randomized, double-blind, placebo-controlled study.
Journal: BMC psychiatry
Published: September 19, 2012
Antipsychotic monotherapy among outpatients with schizophrenia treated with olanzapine or risperidone in Japan: a health care database analysis.
Journal: Neuropsychiatric disease and treatment
Published: June 30, 2012
One-year outcomes in schizophrenia after switching from typical antipsychotics to olanzapine in Japan: an observational study.
Journal: Pragmatic and observational research
Published: June 13, 2012
Schizophrenia Outpatient Health Outcomes study: twelve-month findings.
Journal: Pragmatic and observational research
Published: June 06, 2012
Improved outcomes following a switch to olanzapine treatment from risperidone treatment in a 1-year naturalistic study of schizophrenia patients in Japan.
Journal: Psychiatry and clinical neurosciences
Published: May 26, 2012
Last Updated: 09/26/2026